Article
Criteria for alpha 1-antitrypsin substitution.
Lung - 1 Jan 1990
Viskum K, Kok-Jensen A
Abstract excerpt
The pharmacology and safety of substitution treatment intravenously with alpha 1-antitrypsin (AAT) in patients deficient of AAT has been thoroughly investigated. The clinical efficacy of the treatment has so far not been established. The difficulties and uncertainties involved in defining the rig...
Topics
- Adult
- Aged
- Female
- Follow-Up Studies
- Forced Expiratory Volume
- Humans
- Male
- Middle Aged
- Phenotype
- Pulmonary Emphysema
- alpha 1-Antitrypsin
- alpha 1-Antitrypsin Deficiency
